ARS Pharmaceuticals
San Diego
About ARS Pharmaceuticals
ARS Pharmaceuticals is a stealth pharmaceutical company that developed a novel intranasal epinephrine spray with a unique absorption technology that could be easy-to-use, convenient, and more reliable for patients and loved ones at risk of severe allergic reactions to food, medications and insect bites that could lead to life-threatening anaphylaxis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $175.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Sep 2025)
- Ticker: nasdaq:SPRY
- Website: ars-pharma.com
- Phone: 858-335-1300
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ars-pharmaceuticals-16576 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.